Terms: = Ovarian cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Diagnosis
226 results:
1. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
[TBL] [Abstract] [Full Text] [Related]
2. Reduced healthcare access contributes to delay of care in endometrial cancer.
Fife AJ; Najor AJ; Aspir TB; Haines KE; Vilardo NA; Isani SS; Cowan M; Gressel GM; Ye KQ; Nevadunsky NS; Kuo DY; Lin KY
Gynecol Oncol; 2024 Mar; 182():115-120. PubMed ID: 38262233
[TBL] [Abstract] [Full Text] [Related]
3. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract] [Full Text] [Related]
4. Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Vassallo A; Weber MF; Steinberg J; Webb PM; DeFazio A; Canfell K
PLoS One; 2023; 18(4):e0282851. PubMed ID: 37071628
[TBL] [Abstract] [Full Text] [Related]
5. Sonographic Predictors of ovarian Torsion in Premenarchal Girls.
George JS; Rosen MW; Curci N; Torres ML; Wasnik AP; Smith YR; Quint EH
J Pediatr Adolesc Gynecol; 2023 Aug; 36(4):349-352. PubMed ID: 36944392
[TBL] [Abstract] [Full Text] [Related]
6. Do Fertility Preservation Outcomes in Patients Diagnosed with Lymphoma Differ Based on cancer Stage?
Kocsuta V; Shah S; Lawson AK; Pavone ME
J Adolesc Young Adult Oncol; 2024 Apr; 13(2):300-306. PubMed ID: 36809174
[No Abstract] [Full Text] [Related]
7. Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
Kahn R; Filippova O; Gordhandas S; An A; Straubhar AM; Zivanovic O; Gardner GJ; O'Cearbhaill RE; Tew WP; Grisham RN; Sonoda Y; Long Roche K; Abu-Rustum NR; Chi DS
Gynecol Oncol; 2023 Feb; 169():85-90. PubMed ID: 36521353
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
[TBL] [Abstract] [Full Text] [Related]
9. Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative).
Gaba F; Ash K; Blyuss O; Bizzarri N; Kamfwa P; Ramirez PT; Kotsopoulos IC; Chandrasekaran D; Gomes N; Butler J; Nobbenhuis M; Ind T; Heath O; Barton D; Jeyarajah A; Brockbank E; Lawrence A; Dilley J; Manchanda R; Phadnis S; Soar GO
Int J Gynecol Cancer; 2022 Dec; 32(12):1606-1610. PubMed ID: 36379595
[TBL] [Abstract] [Full Text] [Related]
10. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.
Yap S; Vassallo A; Goldsbury D; O'Connell DL; Brand A; Emery J; DeFazio A; Canfell K; Steinberg J
Cancer Causes Control; 2023 Jan; 34(1):47-58. PubMed ID: 36209449
[TBL] [Abstract] [Full Text] [Related]
11. Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region.
Elalaoui SC; Laarabi FZ; Afif L; Lyahyai J; Ratbi I; Jaouad IC; Doubaj Y; Sahli M; Ouhenach M; Sefiani A
Breast Cancer Res Treat; 2022 Jul; 194(1):187-198. PubMed ID: 35578052
[TBL] [Abstract] [Full Text] [Related]
12. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
[TBL] [Abstract] [Full Text] [Related]
13. Health Care Utilization Prior to ovarian cancer diagnosis in Publicly Insured Individuals in New York State.
Gates Kuliszewski M; Boscoe FP; Wagner VL; Schymura MJ
J Registry Manag; 2021; 48(3):126-137. PubMed ID: 35413730
[TBL] [Abstract] [Full Text] [Related]
14. The impact of preoperative imaging on wait times, surgical approach and overall survival in endometrioid endometrial cancers.
Schnarr KL; Seow H; Pond GR; Helpman L; Elit LM; O'Leary E; Kong I
Gynecol Oncol; 2022 May; 165(2):317-322. PubMed ID: 35248391
[TBL] [Abstract] [Full Text] [Related]
15. Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018.
Spradling PR; Xing J; Zhong Y; Rupp LB; Moorman AC; Lu M; Teshale EH; Schmidt MA; Daida YG; Boscarino JA; Gordon SC
J Infect Dis; 2022 Sep; 226(5):896-900. PubMed ID: 35039863
[TBL] [Abstract] [Full Text] [Related]
16. Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer.
Gamble CR; Chen L; Szamreta E; Monberg M; Hershman D; Wright J
Arch Gynecol Obstet; 2022 Jun; 305(6):1647-1654. PubMed ID: 34993579
[TBL] [Abstract] [Full Text] [Related]
17. Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study.
Shim SH; Lim MC; Lee D; Won YJ; Ha HI; Chang HK; Cho H
J Gynecol Oncol; 2022 Jan; 33(1):e5. PubMed ID: 34783208
[TBL] [Abstract] [Full Text] [Related]
18. Trends in diagnosis and Treatment of Metastatic cancer in the United States.
Lehrer EJ; Stoltzfus KC; Jones BM; Gusani NJ; Walter V; Wang M; Trifiletti DM; Siva S; Louie AV; Zaorsky NG
Am J Clin Oncol; 2021 Nov; 44(11):572-579. PubMed ID: 34560720
[TBL] [Abstract] [Full Text] [Related]
19. How do age and social environment affect the dynamics of death hazard and survival in patients with breast or gynecological cancer in France?
Poiseuil M; Tron L; Woronoff AS; Trétarre B; Dabakuyo-Yonli TS; Fauvernier M; Roche L; Dejardin O; Molinié F; Launoy G;
Int J Cancer; 2022 Jan; 150(2):253-262. PubMed ID: 34520579
[TBL] [Abstract] [Full Text] [Related]
20. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; Primm K; Giordano SH; Meyer LA
Cancer; 2021 Nov; 127(22):4151-4160. PubMed ID: 34347287
[TBL] [Abstract] [Full Text] [Related]
[Next]
